Investing.com - MorphoSys ADR (NASDAQ: MOR) reported fourth quarter EPS of $1.22, $1.73 better than the analyst estimate of $-0.51. Revenue for the quarter came in at $59M versus the consensus estimate of $64.11M.
MorphoSys ADR's stock price closed at $18.04. It is up 85.60% in the last 3 months and up 354.41% in the last 12 months.
MorphoSys ADR saw positive EPS revisions and negative EPS revisions in the last 90 days. See MorphoSys ADR's stock price’s past reactions to earnings here.
According to InvestingPro, MorphoSys ADR's Financial Health score is "good performance".
Check out MorphoSys ADR's recent earnings performance, and MorphoSys ADR's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar